Previous Article | Next Article ![]()
Infection and Immunity, December 1999, p. 6710-6714, Vol. 67, No. 12
Division of Geographic Medicine and
Infectious Diseases, New England Medical Center and Tufts
University School of Medicine, Boston, Massachusetts 02111
Received 16 August 1999/Returned for modification 9 September
1999/Accepted 17 September 1999
We produced isogenic Escherichia coli K-12 lysogens of
seven different Shiga toxin 2 (Stx2)-encoding bacteriophages derived from clinical Shiga toxin-producing E. coli (STEC) isolates
of serotypes O157:H7, O145, O111, and O83 to assess the variability among these phages and determine if there were phage-related
differences in toxin production. Phage genomic restriction fragment
length polymorphisms (RFLP) and superinfection resistance studies
revealed significant differences among these phages and allowed the
seven phages to be placed into five distinct groups. Experiments
revealed striking differences in spontaneous phage and toxin production that were correlated with the groupings derived from the RFLP and
resistance studies. These results suggest that the genotype of the Stx2
prophage can influence the level of phage release and toxin expression
by host strains and thus may be relevant to STEC pathogenesis.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Isogenic Lysogens of Diverse Shiga Toxin 2-Encoding
Bacteriophages Produce Markedly Different Amounts of Shiga
Toxin
*
Corresponding author. Mailing address: Division of
Geographic Medicine and Infectious Diseases, New England Medical Center no. 041, 750 Washington St., Boston, MA 02111. Phone: (617) 636-7618. Fax: (617) 636-5292. E-mail:
matthew.waldor{at}es.nemc.org.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|